Battle TE - Search Results

1

Battle TE, Frank DA. Battle TE, et al. Curr Mol Med. 2002 Jun;2(4):381-92. doi: 10.2174/1566524023362456. Curr Mol Med. 2002. PMID: 12108949 Review.

2

In vivo activation of signal transducer and activator of transcription 1 after CD154 gene therapy for chronic lymphocytic leukemia is associated with clinical and immunologic response.

Battle TE, Wierda WG, Rassenti LZ, Zahrieh D, Neuberg D, Kipps TJ, Frank DA. Battle TE, et al. Clin Cancer Res. 2003 Jun;9(6):2166-72. Clin Cancer Res. 2003. PMID: 12796382

3

STAT1 mediates differentiation of chronic lymphocytic leukemia cells in response to Bryostatin 1.

Battle TE, Frank DA. Battle TE, et al. Blood. 2003 Oct 15;102(8):3016-24. doi: 10.1182/blood-2002-09-2972. Epub 2003 Jul 10. Blood. 2003. PMID: 12855573 Free article.

4

Sustained complete remission of CLL associated with the use of a Chinese herbal extract: case report and mechanistic analysis.

Battle TE, Castro-Malaspina H, Gribben JG, Frank DA. Battle TE, et al. Leuk Res. 2003 Sep;27(9):859-63. doi: 10.1016/s0145-2126(03)00009-2. Leuk Res. 2003. PMID: 12804645

5

Oral fludarabine has significant activity in patients with previously untreated chronic lymphocytic leukemia, and leads to increased STAT1 levels in vivo.

Friedberg JW, Dong DA, Li S, Kim H, Stephans K, Noonan K, Neuberg D, Gribben JG, Fisher DC, Freedman AS, Takvorian T, Jurgens R, Battle TE, Frank DA. Friedberg JW, et al. Among authors: battle te. Leuk Res. 2004 Feb;28(2):139-47. doi: 10.1016/s0145-2126(03)00213-3. Leuk Res. 2004. PMID: 14654078 Clinical Trial.

6

The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells.

Battle TE, Arbiser J, Frank DA. Battle TE, et al. Blood. 2005 Jul 15;106(2):690-7. doi: 10.1182/blood-2004-11-4273. Epub 2005 Mar 31. Blood. 2005. PMID: 15802533 Free article.

7

Signal transducer and activator of transcription 1 activation in endothelial cells is a negative regulator of angiogenesis.

Battle TE, Lynch RA, Frank DA. Battle TE, et al. Cancer Res. 2006 Apr 1;66(7):3649-57. doi: 10.1158/0008-5472.CAN-05-3612. Cancer Res. 2006. PMID: 16585190

8

A small-molecule enhancer of signal transducer and activator of transcription 1 transcriptional activity accentuates the antiproliferative effects of IFN-gamma in human cancer cells.

Lynch RA, Etchin J, Battle TE, Frank DA. Lynch RA, et al. Among authors: battle te. Cancer Res. 2007 Feb 1;67(3):1254-61. doi: 10.1158/0008-5472.CAN-06-2439. Cancer Res. 2007. PMID: 17283162

9

CD40 activation of carcinoma cells increases expression of adhesion and major histocompatibility molecules but fails to induce either CD80/CD86 expression or T cell alloreactivity.

Vonderheide RH, Butler MO, Liu JF, Battle TE, Hirano N, Gribben JG, Frank DA, Schultze JL, Nadler LM. Vonderheide RH, et al. Among authors: battle te. Int J Oncol. 2001 Oct;19(4):791-8. doi: 10.3892/ijo.19.4.791. Int J Oncol. 2001. PMID: 11562757

10

A recombinant IL-4-Pseudomonas exotoxin inhibits protein synthesis and overcomes apoptosis resistance in human CLL B cells.

Kay NE, Bone ND, Lee YK, Jelinek DF, Leland P, Battle TE, Frank DA, Puri RK. Kay NE, et al. Among authors: battle te. Leuk Res. 2005 Sep;29(9):1009-18. doi: 10.1016/j.leukres.2004.11.025. Epub 2005 Apr 12. Leuk Res. 2005. PMID: 16038727

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page